Rezulin Toxicity Reporting Should Be Investigated - Sen. Ashcroft
Executive Summary
An investigation of Warner-Lambert's reporting of Rezulin liver toxicity during clinical trials should be held immediately, Sen. Ashcroft (R-Mo.) urged HELP Committee Chairman Jeffords (R-Vt.) in a March 16 letter.
You may also be interested in...
Rep. Bliley Cautions FDA About Internal Investigation Of "Whistleblower"
The "basis and timing" for FDA's internal investigation of a scientist who raised issues about Warner-Lambert's Rezulin (troglitazone) is "puzzling," House Commerce Committee Chairman Bliley (R-Va.) wrote in a March 22 letter.
Rep. Bliley Cautions FDA About Internal Investigation Of "Whistleblower"
The "basis and timing" for FDA's internal investigation of a scientist who raised issues about Warner-Lambert's Rezulin (troglitazone) is "puzzling," House Commerce Committee Chairman Bliley (R-Va.) wrote in a March 22 letter.
SmithKline Avandia Recommended Only For Combination Use By CPMP
SmithKline Beecham's thiazolidinedione antidiabetic Avandia is in the final stages of EU approval following a positive recommendation by the Committee for Proprietary Medicinal Products March 16.